01—Abstract
Summary
Summary of the 8-K filed May 7, 2026. Cited figures are marked; the original filing is the authoritative source.
IQVIA Holdings Inc. (IQV) filed a Form 8-K on May 7, 2026 to disclose that its board of directors authorized the repurchase of an additional $2,000 milliona of the company's common stock under its existing equity repurchase program (the "Repurchase Program").
The filing states this brings the total remaining authorization to $3,217 millionb, which the accompanying press release rounds to $3.2 billion. The filing emphasizes that the Repurchase Program does not obligate the company to buy any particular amount of stock and may be modified, extended, suspended or discontinued at any time. Timing and amount of repurchases are set by management based on factors including the market price of the stock, corporate requirements and overall market conditions.
Purchases may occur in open market transactions through a broker-dealer, in block trades, or in privately negotiated transactions, and the program has no expiration date. The company also states that it has, from time to time, repurchased shares through private or other transactions outside the Repurchase Program, and that it may discontinue repurchases without notice. The press release, filed as Exhibit 99.1, is titled "IQVIA Board of Directors Approves $2c Billion Increase in Share Repurchase Authorization" and describes IQVIA as a global provider of clinical research services, commercial insights and healthcare intelligence.
02—Key points
Key Highlights
- Board authorized an additional $2,000 million (announced as $2 billion) of common stock repurchases under the existing Repurchase Program.
- Total remaining repurchase authorization stands at $3,217 million, or $3.2 billion per the press release.
- The Repurchase Program has no expiration date and imposes no obligation to repurchase any specific amount of stock.
- Repurchases may be made in open market transactions through a broker-dealer, in block trades, or in privately negotiated transactions.
- The company may repurchase shares outside the program and may discontinue repurchases without notice at any time.
- Execution timing depends on stock price, corporate requirements and overall market conditions, as determined by management.
03—Questions
Frequently Asked Questions
How much stock buyback capacity does IQVIA have after this announcement?
The filing states that the board's additional $2,000 million authorization brings the total remaining authorization under the Repurchase Program to $3,217 million, which the press release describes as $3.2 billion.
Is IQVIA required to buy back a specific amount of stock under this program?
No. The filing states that the Repurchase Program does not obligate the company to repurchase any particular amount of common stock and may be modified, extended, suspended or discontinued at any time.
Does the Repurchase Program have an expiration date?
No. The filing states that the Repurchase Program does not have an expiration date.
How will IQVIA carry out repurchases?
The filing states that purchases may be made in open market transactions effected through a broker-dealer at prevailing market prices, in block trades, or in privately negotiated transactions. The company may also repurchase shares through private or other transactions outside the program.
What factors will determine the timing and amount of repurchases?
According to the filing, management determines timing and amount based on factors such as the market price of the company's common stock, the company's corporate requirements, and overall market conditions.
04—Continue